135 related articles for article (PubMed ID: 36029561)
1. Discovery of novel non-nucleoside inhibitors with high potency and selectivity for DNA methyltransferase 3A.
Yu J; Chai X; Pang J; Wang Z; Zhao H; Xie T; Xu L; Sheng R; Li D; Zeng S; Hou T; Kang Y
Eur J Med Chem; 2022 Nov; 242():114646. PubMed ID: 36029561
[TBL] [Abstract][Full Text] [Related]
2. Identifying novel selective non-nucleoside DNA methyltransferase 1 inhibitors through docking-based virtual screening.
Chen S; Wang Y; Zhou W; Li S; Peng J; Shi Z; Hu J; Liu YC; Ding H; Lin Y; Li L; Cheng S; Liu J; Lu T; Jiang H; Liu B; Zheng M; Luo C
J Med Chem; 2014 Nov; 57(21):9028-41. PubMed ID: 25333769
[TBL] [Abstract][Full Text] [Related]
3. Mechanistic Insights into Harmine-Mediated Inhibition of Human DNA Methyltransferases and Prostate Cancer Cell Growth.
Cho CC; Lin CJ; Huang HH; Yang WZ; Fei CY; Lin HY; Lee MS; Yuan HS
ACS Chem Biol; 2023 Jun; 18(6):1335-1350. PubMed ID: 37188336
[TBL] [Abstract][Full Text] [Related]
4. Discovery of novel DNA methyltransferase 3A inhibitors via structure-based virtual screening and biological assays.
Shao Z; Xu P; Xu W; Li L; Liu S; Zhang R; Liu YC; Zhang C; Chen S; Luo C
Bioorg Med Chem Lett; 2017 Jan; 27(2):342-346. PubMed ID: 27899265
[TBL] [Abstract][Full Text] [Related]
5. DNA Methyltransferase 3A: A Significant Target for the Discovery of Inhibitors as Potent Anticancer Drugs.
Feng Q; Duan H; Zhou X; Wang Y; Zhang J; Zhang H; Chen G; Bao X
Mini Rev Med Chem; 2024; 24(5):507-520. PubMed ID: 37642180
[TBL] [Abstract][Full Text] [Related]
6. In silico study of selective inhibition mechanism of S-adenosyl-L-methionine analogs for human DNA methyltransferase 3A.
Stillson NJ; Anderson KE; Reich NO
Comput Biol Chem; 2023 Feb; 102():107796. PubMed ID: 36495748
[TBL] [Abstract][Full Text] [Related]
7. DNA methyltransferases 3A and 3B target specific sequences during mouse gastrulation.
Mukamel Z; Lifshitz A; Mittnenzweig M; Chomsky E; Schwartzman O; Ben-Kiki O; Zerbib M; Tanay A
Nat Struct Mol Biol; 2022 Dec; 29(12):1252-1265. PubMed ID: 36510023
[TBL] [Abstract][Full Text] [Related]
8. Identification of a potential DNA methyltransferase (DNMT) inhibitor.
Jan Z; Ahmed WS; Biswas KH; Jithesh PV
J Biomol Struct Dyn; 2024 Jun; 42(9):4730-4744. PubMed ID: 37424222
[TBL] [Abstract][Full Text] [Related]
9. 7-Aminoalkoxy-Quinazolines from Epigenetic Focused Libraries Are Potent and Selective Inhibitors of DNA Methyltransferase 1.
Medina-Franco JL; López-López E; Martínez-Fernández LP
Molecules; 2022 Apr; 27(9):. PubMed ID: 35566242
[TBL] [Abstract][Full Text] [Related]
10. Enzymology of Mammalian DNA Methyltransferases.
Jurkowska RZ; Jeltsch A
Adv Exp Med Biol; 2022; 1389():69-110. PubMed ID: 36350507
[TBL] [Abstract][Full Text] [Related]
11. Overexpression of DNA (Cytosine-5)-Methyltransferase 1 (DNMT1) And DNA (Cytosine-5)-Methyltransferase 3A (DNMT3A) Is Associated with Aggressive Behavior and Hypermethylation of Tumor Suppressor Genes in Human Pituitary Adenomas.
Ma HS; Wang EL; Xu WF; Yamada S; Yoshimoto K; Qian ZR; Shi L; Liu LL; Li XH
Med Sci Monit; 2018 Jul; 24():4841-4850. PubMed ID: 30002361
[TBL] [Abstract][Full Text] [Related]
12. DNA Methyltransferase Inhibitors and their Therapeutic Potential.
Zhou Z; Li HQ; Liu F
Curr Top Med Chem; 2018; 18(28):2448-2457. PubMed ID: 30465505
[TBL] [Abstract][Full Text] [Related]
13. A novel class of selective non-nucleoside inhibitors of human DNA methyltransferase 3A.
Huang S; Stillson NJ; Sandoval JE; Yung C; Reich NO
Bioorg Med Chem Lett; 2021 May; 40():127908. PubMed ID: 33705897
[TBL] [Abstract][Full Text] [Related]
14. Insight into the selective binding mechanism of DNMT1 and DNMT3A inhibitors: a molecular simulation study.
Xie T; Yu J; Fu W; Wang Z; Xu L; Chang S; Wang E; Zhu F; Zeng S; Kang Y; Hou T
Phys Chem Chem Phys; 2019 Jun; 21(24):12931-12947. PubMed ID: 31165133
[TBL] [Abstract][Full Text] [Related]
15. DNA methyltransferase-1 inhibitors as epigenetic therapy for cancer.
Singh V; Sharma P; Capalash N
Curr Cancer Drug Targets; 2013 May; 13(4):379-99. PubMed ID: 23517596
[TBL] [Abstract][Full Text] [Related]
16. Decreased DNA methyltransferase 3A and 3B mRNA expression in peripheral blood mononuclear cells and increased plasma SAH concentration in adult patients with idiopathic thrombocytopenic purpura.
Tao J; Yang M; Chen Z; Huang Y; Zhao Q; Xu J; Ren H; Zhao H; Chen Z; Ren Q; Yang R
J Clin Immunol; 2008 Sep; 28(5):432-9. PubMed ID: 18683034
[TBL] [Abstract][Full Text] [Related]
17. Design, synthesis, and biological evaluation of novel carbazole derivatives as potent DNMT1 inhibitors with reasonable PK properties.
Li E; Wang K; Zhang B; Guo S; Xiao S; Pan Q; Wang X; Chen W; Wu Y; Xu H; Kong X; Luo C; Chen S; Liu B
J Enzyme Inhib Med Chem; 2022 Dec; 37(1):1537-1555. PubMed ID: 35670075
[TBL] [Abstract][Full Text] [Related]
18. 5-Aza-cytidine is a potent inhibitor of DNA methyltransferase 3a and induces apoptosis in HCT-116 colon cancer cells via Gadd45- and p53-dependent mechanisms.
Schneider-Stock R; Diab-Assef M; Rohrbeck A; Foltzer-Jourdainne C; Boltze C; Hartig R; Schönfeld P; Roessner A; Gali-Muhtasib H
J Pharmacol Exp Ther; 2005 Feb; 312(2):525-36. PubMed ID: 15547111
[TBL] [Abstract][Full Text] [Related]
19. Epigenetic regulation of motor neuron cell death through DNA methylation.
Chestnut BA; Chang Q; Price A; Lesuisse C; Wong M; Martin LJ
J Neurosci; 2011 Nov; 31(46):16619-36. PubMed ID: 22090490
[TBL] [Abstract][Full Text] [Related]
20. Methyltransferase DNMT3B in leukemia.
Zhang H; Ying H; Wang X
Leuk Lymphoma; 2020 Feb; 61(2):263-273. PubMed ID: 31547729
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
